Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizThe Patent Quality Arguments of Ocean Tomo
By Lawrence B. Ebert, Esq.
The post of July 13 noted text by Joff Wild of IAM concerning an appropriate response to the Ocean Tomo paper from hypothetical critics-->
However, what the critics would be better off doing is to read through the whole article very carefully to work out whether the research that the two authors have done is flawed. If it is, they need to explain why and how the flaws distort the real picture. In other words, they need to address the message rather than the messengers.
While accepting the general premise that those advocating a decline in patent quality have not presented good arguments, IPBiz notes problems in the Ocean Tomo position advocating an increase in patent quality. In the following, IPBiz notes some deficiencies in the Ocean Tomo paper-->
The first sentence of ?Patent Quality? states:
The question ?What is Patent Quality?? is
one that has long been answered not by the
authors of this paper but by the marketplace
itself.
While IPBiz would agree with the general concept that arguments made by certain
legal academics of a lack of patent ?quality? are flawed, IPBiz finds a lack of depth in
the arguments from the Ocean Tomo people.
A rather obvious and eye-catching flaw with the paper is the citation practice. While the authors make out well, in fact better than the US Supreme Court does, the shoddy worksmanship does attest to a lack of quality in the paper. Footnote 20, a self-citation to author Barney, illustrates that the authors are capable of doing a complete citations:
J. Barney, ?A Study of Patent Mortality Rates: Using Statistical Survival Analysis to Rate and Value Patent Assets,? AIPLA Quarterly Journal, 30, no. 3, pp. 317?352 (2002).
However, one sees in footnote 10 that the Supreme Court does not fare as well:
KSR International Co. v. Teleflex, Inc. (04-1350), U.S.
Supreme Court (Decided April 30, 2007).
In July 2008, there is no excuse to cite the April 2007 KSR case in such a way. Academics are also victimized by the shoddy workmanship of the authors:
Footnote 9: See, e.g., C. Shapiro, Navigating the Patent Thicket?Cross-
Licenses, Patent Pools and Standard-Setting, University of Cali-
fornia at Berkeley (March 2001).
Footnote 19: K. Moore, ?Worthless Patents? (July 2004). George
Mason Law & Economics Research Paper No. 04-29
X
More problematic than the bad citing is the false citing. Of the patent allowance discussion,
initiated by Quillen and Webster, the authors paraphrase the Quillen and Webster argument without citing Quillen and Webster:
For one thing, it turns out that patent
allowance rates are devilishly difficult to define given
the common practice in the U.S. of filing multiple
continuation applications attempting to patent essen-
tially the same invention that may already have been
previously rejected by the Patent Office.
X
Aside from not crediting Quillen and Webster, the authors don?t discuss the various
papers showing that continuation applications are generally not multiple attempts to patent an already rejected invention. So, in this case, the authors are wrong on the cite and are wrong on the substance.
Of the patent quality debate itself, the authors identify two themes:
The first broad theme centers on the concept of an
overburdened patent office that is understaffed and
ill-equipped to maintain pace with burgeoning new
technologies and a perceived flood of new patent fil-
ings. This argument is usually heralded by a shocking,
if not amusing, parade of patent horribles?bogus,
dubious or outright wacky patents?which are of-
fered up as evidence of a patent system run amuck.
A particular parade favorite these days is the now
infamous ?peanut-butter and jelly sandwich? patent
(U.S. Pat. No. 6,004,596).
[The authors neglect to note that the peanut-butter and jelly sandwich died
as a result of re-examination.]
A more apt theme, addressed later on below, argues that the patentability
standards and/or applications of the patentability
standards by the Patent Office are too low, resulting
in the proliferation of many dubious patents on little
more than trivial improvements.
X
Of the first theme, the authors write:
This by now familiar rhetoric and anecdotal
evidence seems logical enough, even compelling at
times. But, several key underlying numerical and
statistical trends simply do not support the asserted
conclusion that the Patent Office is overburdened or
that quality of U.S. patent examination is flagging.
In fact, some of the statistical evidence we have
analyzed seems to suggest that patent examination
quality has either remained steady or has even im-
proved somewhat over the past five years.
X
The authors point out that current % increases in patent applications are comparable to some increases in past years. Of the pendency problem, the authors write:
In fact, a growing backlog of cases under peak
usage conditions is the expected and desired result
of a patent examination system that is maintaining
standards and quality controls at steady levels.
X
Of course, a growing backlog can arise for other reasons.
The authors note arguments that overburdened examiners may lead to
poor patent quality:
Examiners, the argument goes, being
highly pressed for time and resources, do not have
adequate opportunity to conduct sufficiently thor-
ough prior art .
The authors attempt to negate this by observing an increase in cited
art:
While this significant growth in prior art citations
may not be conclusive evidence of increased search
thoroughness or search quality, it is certainly sug-
gestive evidence and is plainly inconsistent with
the notion that search thoroughness and search
quality have somehow declined in recent years.
The authors neglect to mention that cited art on an issued patent can
arise from two sources: the examiner (892 form) and the applicant (1449 form).
In the absence of knowing ?which? source has created the ?significant? growth, conclusions that examiners are conducting more thorough searches are unwarranted.
The authors address arguments asserting the granting of overly broad claims:
Examiners granting patents with overly broad
claims is another commonly cited anecdotal factor
in support of the flagging quality and overburdened-
patent-office argument.
The authors attempt to negate this by comparing the average word count in an
independent claim in 2007 (160.1) to the word count in 2003 (153.3). This drop in average
word count is supposed to indicate that claims are becoming more complicated (less broad).
The validity of this correlation is not proved.
As to impact of KSR, the authors suggest that KSR caused the recent drop in patent allowance rate:
Patent allowance rates for the
first quarter of 2008 (the first post-KSR statistics
available) have dropped to a new low of 44 per-
cent.
But patent allowance rates had been dropping before KSR.
There are flaws in the article which may distort the true picture.
Full post as published by IPBiz on July 23, 2008 (boomark / email).
TomoTherapy Incorporated
NASD: TOMO
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Trans Ocean
Recalls Cracked Pepper Style Smoked Salmon
Clearwire Service
alleging poor quality and unfairly charging early termination fees.

Ocean Tomo Announces Agenda for Spring 2008 Live IP Auction & Summit
General Counsel - Ocean Tomo, LLC
Technical Analyst - Small Corporation - Chicago, Ill.
Reports Are In on Ocean Tomo's Record-Breaking Patent Auction
PatentCafe Adds New Patent Quality Reports to Its Free CAFC Library








